Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Hubble Therapeutics Logo
Hubble Therapeutics Growth Score
68
CB Rank
84048
Heat Score
8
Hubble Therapeutics is a biotechnology research company that offers gene therapy for leber congenital amaurosis type 16.
Founded
obfuscation
PrivateSeries A Hanover, New Hampshire, United States1-10 hubbletx.com
Biotechnology
Health Care
Therapeutics
Wellness
Overview

Hubble Therapeutics
Total Funding
obfuscation
Growth Score
68
Heat Score
8

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score68
-3 pts
in past quarter
Heat Score 8
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Hubble Therapeutics

CB Rank
84048
Hubble Therapeutics is a biotechnology research company that offers gene therapy for leber congenital amaurosis type 16.
Founded
obfuscation
PrivateSeries A Hanover, New Hampshire, United States1-10 hubbletx.com
Biotechnology
Health Care
Therapeutics
Wellness

Funding Rounds

Series A
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Details

Legal Name Hubble Therapeutics, LLC
Operating Status Active
Company Type For Profit
Phone Number +1 617 780-2375
Predictions & Insights

Growth Insight

See this Growth Insight
Hubble Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A
obfuscation
Series A - Hubble Therapeutics Logo
Series A - Hubble Therapeutics
1
obfuscation
WARF VenturesSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Board Members and Advisors 1

Board Members and Advisors

News

News and Press

News•Apr 1, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 26, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 26, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 25, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$225KThis year, Hubble Therapeutics is projected to spend $225K on IT, according to Aberdeen.

Active Website Tech Count

4Hubble Therapeutics is actively using 4 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, CloudFront, and  SiteGround CAPTCHA.
Sub-Organizations
Frequently Asked Questions

Where is Hubble Therapeutics's headquarters? Hubble Therapeutics is located in Hanover, New Hampshire, United States.Who invested in Hubble Therapeutics? Hubble Therapeutics is funded by WARF Ventures.When was the last funding round for Hubble Therapeutics? Hubble Therapeutics closed its last funding round on
obfuscation
from a Series A round.Who are Hubble Therapeutics's competitors? Alternatives and possible competitors to Hubble Therapeutics may include Atsena Therapeutics, LEXEO Therapeutics, and  Beacon Therapeutics.How much funding has Hubble Therapeutics raised to date? Hubble Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8c8a01a 1)
|